Search

Your search keyword '"Flynn, Patricia M."' showing total 754 results

Search Constraints

Start Over You searched for: Author "Flynn, Patricia M." Remove constraint Author: "Flynn, Patricia M."
754 results on '"Flynn, Patricia M."'

Search Results

3. Metabolomic profiling of preterm birth in pregnant women living with HIV

4. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India

5. Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial

6. Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study

7. The role of cultural beliefs and distress in adherence to recommended physical activity among patients with type 2 diabetes mellitus

8. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men.

9. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women.

10. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial

11. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.

13. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

15. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

17. Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil Fumarate

19. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate : A Randomized, Placebo-Controlled Trial

20. Introduction

21. Conclusion

22. Introduction

24. Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial

25. Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

26. Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein

28. Competitive Strategies of States: A Life-Cycle Perspective. EQW Working Papers.

29. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis

33. Introduction

43. Contributors

46. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India

47. Contributors

48. Introduction

50. Introduction

Catalog

Books, media, physical & digital resources